 "Metropolis Healthcare share price falls 14% after block deals")
Shares of Metropolis Healthcare slumped 14 per cent to Rs 1,152 on the BSE on Wednesday after more than 13 per cent of the company's equity changed hands via block deals in early morning trade.
At 09:15 am, around 6.76 million shares, representing 13.5 per cent of the healthcare services company's total equity, changed hands on the BSE, the exchange data shows. The names of the buyers were not ascertained immediately.
According to media reports, private equity giant Carlyle was set to sell stake in Metropolis Healthcare via block deal.
As on December 31, 2019, investor CA Lotus Investments, a subsidiary of US-based private equity firm Carlyle Group, held 7.18 million shares, or 14.31 per cent stake, in Metropolis Healthcare, the shareholding pattern data shows.
The stock has corrected 45 per cent from its all-time high level of Rs 2,110, touched on March 3, 2020. The company had debuted at the bourses in April last year after raising Rs 1,204 crore through its initial public offering (IPO), at issue price of Rs 880 per share.
At 09:30 am, Metropolis Healthcare was trading 10 per cent lower at Rs 1,203 on the BSE, as compared to 1.6 per cent rise in the S&P BSE Sensex. A combined 78.7 million shares have changed hands on the counter on the NSE and BSE so far.
At 09:15 am, around 6.76 million shares, representing 13.5 per cent of the healthcare services company's total equity, changed hands on the BSE, the exchange data shows. The names of the buyers were not ascertained immediately.
According to media reports, private equity giant Carlyle was set to sell stake in Metropolis Healthcare via block deal.
As on December 31, 2019, investor CA Lotus Investments, a subsidiary of US-based private equity firm Carlyle Group, held 7.18 million shares, or 14.31 per cent stake, in Metropolis Healthcare, the shareholding pattern data shows.
The stock has corrected 45 per cent from its all-time high level of Rs 2,110, touched on March 3, 2020. The company had debuted at the bourses in April last year after raising Rs 1,204 crore through its initial public offering (IPO), at issue price of Rs 880 per share.
At 09:30 am, Metropolis Healthcare was trading 10 per cent lower at Rs 1,203 on the BSE, as compared to 1.6 per cent rise in the S&P BSE Sensex. A combined 78.7 million shares have changed hands on the counter on the NSE and BSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%